Evidence map›Paper›PMID 41062564›Full record

ArticleScientific reports2025

CD68- and CD163-positive tumor-associated macrophages in renal clear cell carcinoma.

Yingying Yang, Di Sun, Xiaohong Ma, Tianqi Wang, Jitao Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yingying Yang *Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
Di Sun *Department of Pathology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
Xiaohong MaDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China.
Tianqi WangDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China. weatherking@hotmail.com.
Jitao WuDepartment of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, NO. 20 East Yuhuangding Road, Yantai, 264000, Shandong, China. wjturology@163.com.

Funding

National Natural Science Foundation of China Nos. 82370690Taishan Scholars Program of Shandong Province Nos. tsqn201909199
6 · The paper itself

Abstract

This study aimed to analyze the infiltration of tumor-associated macrophages (TAMs) in clear cell renal cell carcinoma (ccRCC) and to assess their Prognostic significance. This study involved a Cohort of 106 patients with ccRCC who underwent partial or radical nephrectomy. Immunohistochemistry (IHC) was employed to assess the expression of two distinct types of macrophages at various tissue locations. The diagnostic utility of CD68-positive (CD68

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticCarcinoma, Renal CellKidney NeoplasmsReceptors, Cell SurfaceTumor-Associated MacrophagesAdultAgedCD163 AntigenCD68 MoleculeFemaleHumansImmunohistochemistryKaplan-Meier EstimateMacrophagesMaleAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenCD68 antigen, humanCD68 MoleculeReceptors, Cell SurfaceCD163CD68Cellular immunityRenal clear cell carcinomaTumor-associated macrophages

Identifiers

PMID41062564
PMCPMC12508087

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.